Medical Devices

  • Rendering of a spiral-shaped catheter with four electrodes
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    CMS grants NCD for renal denervation, benefiting Medtronic, Recor

    National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.

    By • Oct. 29, 2025
  • Three carts on wheels stand side by side, with one featuring robotic arms and another showing a screen and a controller.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J partners with Nvidia on AI for kidney stone procedures

    The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.

    By • Oct. 28, 2025
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • A headshot of new Olympus CEO Bob White.
    Image attribution tooltip
    Courtesy of Olympus
    Image attribution tooltip

    Olympus execs talk about import alert, GI robot and AI

    CEO Bob White and Chief Strategy Officer Gabriela Kaynor discussed the medtech company’s quality and technology priorities after a year of change.

    By • Oct. 28, 2025
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic links renal denervation to 3-year blood pressure reduction

    Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

    By • Oct. 28, 2025
  • J&J, Auris, Fortis
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J awards first grants from AI surgery fund

    Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.

    By • Oct. 27, 2025
  • The robot-enhanced heart valve replacement system is depicted in an illustration that includes a patient on a table.
    Image attribution tooltip
    Courtesy of CardioPrecision
    Image attribution tooltip
    Profile

    Corcym, CardioPrecision set sights on robotic heart valve replacement

    The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.

    By • Oct. 27, 2025
  • A head shot of Accuray CEO Steve La Neve.
    Image attribution tooltip
    Permission granted by Accuray
    Image attribution tooltip

    Accuray hires Steve La Neve as CEO in transformation effort

    The radiotherapy systems maker unveiled the leadership change and strategy initiatives as it reported a preliminary fiscal first-quarter adjusted loss.

    By • Oct. 24, 2025
  • A ship labeled "Matson" carries several large boxes in front of a port.
    Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Medtech industry closely watching Section 232 investigation

    The investigation, which could be used to impose tariffs for medical products, has raised the attention of several industry groups. Check out MedTech Dive’s roundup of coverage on the 232 probe.

    By • Oct. 24, 2025
  • Eight people line up behind a giant check.
    Image attribution tooltip
    Courtesy of MedTech Innovator
    Image attribution tooltip
    Profile

    Hemorrhage can be a serious problem after pregnancy. Here’s how one medtech founder is tackling it

    Kelsey Mayo, CEO of Armor Medical, received the grand prize in MedTech Innovator’s pitch competition for a wearable technology to detect serious blood loss early.

    By • Oct. 23, 2025
  • Baxter's Heather Knight is pictured with a lamp and sofa in the background.
    Image attribution tooltip
    Permission granted by Baxter International
    Image attribution tooltip

    Solventum hires Heather Knight from Baxter to fill new C-suite post

    Chris Barry, group president of medsurg at Solventum, is leaving the company at the end of the year in connection with Knight’s arrival.

    By • Oct. 23, 2025
  • Image of a brain in purple outline with red details.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CoMind raises $102.5M to develop non-invasive bedside brain monitor

    The company is enrolling patients in an early feasibility trial as part of plans to launch its device in 2027.

    By • Updated Oct. 28, 2025
  • Two clinicians wearing scrubs stand in front of Intuitive Surgical's da Vinci 5 robotic surgery system.
    Image attribution tooltip
    Courtesy of Tampa General Hospital
    Image attribution tooltip

    Intuitive Surgical reports strong Q3 as da Vinci procedures climb

    Intuitive Surgical’s shares surged nearly 15% early Wednesday after the robot maker’s third-quarter sales and earnings topped analysts’ expectations.

    By • Oct. 22, 2025
  • A U.S. flag flies in front of shipping containers and cranes at the Port of Los Angeles on Sept. 26, 2025.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    AHA urges tariff exceptions for certain PPE, medical devices

    The American Hospital Association warned future tariffs arising from the Trump administration’s Section 232 investigation could disrupt access to an array of tools and personal protective equipment.

    By • Oct. 21, 2025
  • A patient and clinician in front of a Hologic breast imaging device
    Image attribution tooltip
    Courtesy of Hologic
    Image attribution tooltip

    Hologic to go private for up to $18.3B

    Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.

    By • Oct. 21, 2025
  • President Donald Trump speaks to reporters at the White House on Oct. 5, 2025, in Washington, D.C.
    Image attribution tooltip
    Tasos Katopodis via Getty Images
    Image attribution tooltip

    MDMA warns Section 232 tariffs could hurt US medtech manufacturing

    The trade group said levies would “needlessly disrupt a globally integrated industry that already meets domestic demand.”

    By • Oct. 21, 2025
  • A person smiles and poses for a professional photo.
    Image attribution tooltip
    Permission granted by Biolinq
    Image attribution tooltip
    Q&A

    Biolinq’s Jared Tangney on making CGMs unintimidating

    The chief technology officer and co-founder explained the technology and design choices that went into Biolinq’s device, which he hopes will be easier to use than other glucose monitors.

    By • Oct. 20, 2025
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom faces proposed class action suit over G7 CGM problems

    The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

    By • Oct. 20, 2025
  • President Donald Trump speaks to reporters at the White House on Aug. 25, 2025, in Washington, D.C.
    Image attribution tooltip
    Chip Somodevilla via Getty Images
    Image attribution tooltip

    AdvaMed calls for series of trade actions in response to Section 232 probe

    In comments submitted to the Trump administration on its medical equipment investigation, the industry group recommended a tariff-free trading bloc with trusted countries among its proposals.

    By • Oct. 20, 2025
  • Person wears Oura ring in a car
    Image attribution tooltip
    Courtesy of Oura
    Image attribution tooltip

    Ōura to pursue FDA clearance of blood pressure feature for smart ring

    The company has received approval to validate and define the feature in a study that is scheduled to start this year.

    By • Oct. 20, 2025
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to buy Nalu Medical for $533M

    Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.

    By • Oct. 17, 2025
  • Histosonics' Edison histotripsy system is pictured in an operating room.
    Image attribution tooltip
    Permission granted by Histosonics
    Image attribution tooltip

    HistoSonics raises $250M to expand use of noninvasive cancer therapy

    The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.

    By • Oct. 17, 2025
  • J&J HQ
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    What J&J’s ortho spinoff means for the industry

    Analysts expect that DePuy Synthes could become a stronger competitor as a standalone company.

    By • Oct. 16, 2025
  • BD CFO Chris DelOrefice wears a suit and tie in a headshot.
    Image attribution tooltip
    Courtesy of BD
    Image attribution tooltip

    BD CFO Chris DelOrefice leaving for new job

    Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.

    By • Oct. 16, 2025
  • The US and Canada flags wave in front of a bridge
    Image attribution tooltip
    Bill Pugliano via Getty Images
    Image attribution tooltip

    To move or not to move? Manufacturers hesitant to nearshore before USMCA review

    While some companies are using regional supply chains or leaning on tariff exemptions by maximizing compliance, others are frozen in place.

    By Shefali Kapadia • Oct. 16, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott CEO: ‘We’re right on time’ to the PFA party

    As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.

    By • Oct. 15, 2025